The Covid-19 pandemic pushed the healthcare industry toward rapid digitalisation, with the rise of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology now changing the way healthcare is delivered and improving patient outcomes.
Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment for psychological and neurological disorders. For pharma and medical devices, AR, VR, and AI are rapidly accelerating drug discovery, manufacturing, and supply chain efficiencies. However, commercial uptake and affordability remain limiting factors to the widespread adoption of new digital products and opportunities.
